Tag /

Intestinal Permeability

Intestinal permeability featured article

A single layer of epithelial cells lines the entire digestive tract, facilitating the exchange of nutrients between the intestine and the bloodstream. This layer, referred to as the intestinal epithelium, must be permeable to nutrients yet impermeable to pathogens.

Increased intestinal permeability (also known as "leaky gut") – a condition in which gaps form between the tight junctions that join enterocytes – allows pathogens to leak through the intestinal barrier and pass directly into the bloodstream, promoting inflammation through a specialized mechanism involving detection by toll-like receptors.

Although commonly associated with gut-related illnesses and autoimmune disorders, disturbed intestinal barrier function is a prominent feature of many chronic diseases via its effects on tissues outside the gut. Intestinal permeability may also contribute to a chronic state of metabolic endotoxemia, which drives...

Episodes

Posted on February 4th 2023 (over 2 years)

Dr. Rhonda Patrick answers audience questions on various health, nutrition, and science topics in this Q&A session.

Posted on July 9th 2022 (almost 3 years)

Dr. Rhonda Patrick answers audience questions on various health, nutrition, and science topics in this Q&A session.

Posted on June 4th 2022 (almost 3 years)

Dr. Rhonda Patrick answers audience questions on various health, nutrition, and science topics in this Q&A session.

Topic Pages

  • Butyrate

    Butyrate is a short-chain fatty acid produced by microbes in the gut during the fermentation of dietary fiber.

  • Intestinal permeability

    Intestinal permeability facilitates nutrient absorption in the gut while excluding environmental toxins and pathogens.

  • Toll-like receptors

    Toll-like receptors are a family of pattern recognition receptors expressed on the surface of immune and other cells that play an important role in intestinal permeability and inflammaging.

News & Publications

  • From the article:

    In a mouse model of ALS, the compound butyrate helped correct a gut microbiome imbalance and reduced gut leakiness – both symptoms of ALS. The treated mice lived also longer compared to mice that weren’t given butyrate.

    […]

    When the researchers fed the ALS-prone mice butyrate in their water, starting when the mice were 35 to 42 days old, the mice showed a restored gut microbiome profile and improved gut integrity. Butyrate-treated mice also showed improved neuromuscular function and delayed onset of ALS symptoms. Treated mice showed symptoms at 150 days old compared to control mice at about 110 days. Treated mice also lived an average 38 days longer than mice not given butyrate.

  • In recent years, vaping, or smoking electronic cigarettes (e-cigarettes), has emerged as a popular substitute for smoking tobacco-containing cigarettes. E-cigarettes produce a vapor that may contain nicotine as well as a variety of toxic substances, including some carcinogens. Findings from a new study suggest that some compounds in e-cigarettes trigger inflammation, promoting a leaky gut.

    Leaky gut, otherwise known as intestinal permeability, is a condition in which gaps form between the tight junctions between the endothelial cells that line the gut. These gaps allow pathogens like bacteria or endotoxins (toxins that are released when bacteria die) to leak through the intestinal wall and pass directly into the bloodstream. Leaky gut has been linked with a number of chronic diseases, including Alzheimer’s disease and cardiovascular disease.

    The authors of the study exposed mice to e-cigarette vapors for one hour per day and then they examined the animals' colons at one week and three months after the chronic exposure. Then they measured gene expression in the colons. They also built gut enteroids – three-dimensional tissue models that incorporate many of the features of human gut tissue, including an epithelial layer surrounding a functional lumen and all of the cell types normally found in the gut. They exposed the enteroids to e-cigarette vapor (with or without nicotine).

    They found that exposure to e-cigarette vapor promoted leaky gut, increasing the susceptibility of the gut lining to bacterial infections, and triggering gut inflammation. Use of the two models established that the primary components in the vapor responsible for the harmful effects were propylene glycol and vegetable glycerol, compounds present in more than 99 percent of all e-cigarettes. They also found that e-cigarette vapor altered expression of genes involved in the cellular response to stress, infection, and inflammation.

    These findings demonstrate that commonly used substances present in e-cigarettes promote leaky gut and drive inflammation and provide insights into the long-term health effects of e-cigarettes. They also underscore public health efforts to reduce e-cigarette use.